Being recognized as a world-renowned organization, OMICS International takes pride to introduce the commencement of “14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics” from October 17-19, 2016 at Kuala Lumpur, Malaysia. Special interest and theme of this conference is: “A step towards translating novel therapies to control Diabetes”. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. OMICS International’s Diabetes Medicare 2016 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.
OMICS Publishing Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.
OMICS International welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetes Medicare 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetes Medicare 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Medicare 2016 is where the future of management and novel therapeutics for the disease intersects.
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2013, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.
- Diabetes Pathophysiology
- Clinical Practices in Diabetes
- Trends in Diabetes Complication
- Diabetes Medications & Pharmacotherapy
- Alternative Therapies for Diabetes
- Diabetes Market and Business Analysis
- Diabetes Nutrition
- Recent Technologies for Diabetes care and Management
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://diabeticmedications.conferenceseries.com/